Plenary Session III Featured

9:00 AM - 10:25 AM CST Saturday, January 16

During this session, we will explore the new hope for extending the indications for neuromodulation to new frontiers. In many cases, these breakthrough areas in neuromodulation are being funded by large investments by the NIH and other agencies. Key opinion leaders will review innovative new research and clinical trials being conducted in respiratory, and cardiac function.  

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Describe key progress in the field of neuromodulation for cardiac function.
  • Identify indications for neuromodulation for respiratory function and its impact on functional and quality of life.
  • Discuss ways to counteract and prevent racism and bias in medicine.


David A. Provenzano, MD

Introduction of Honored Guest Lecturer

David A. Provenzano, MD

Honored Guest Lecturer: Fighting Bias and Racism in Medicine by Enhancing Diversity

Quinn Capers IV, MD

Neuromodulation and Obstructive Sleep Apnea

David T. Kent, MD

Neurocardiology and Neuromodulation

Kalyanam Shivkumar, MD PhD

Research on Off-Label Use for New And/Or Orphan Indications in Neuromodulation

Elias Veizi, MD PhD

Live Q&A Discussion

Faculty and Presentations subject to change.